Patents Assigned to Aspreva International Ltd.
  • Publication number: 20110269755
    Abstract: The disclosure provides compositions and methods for the treatment of vascular, autoimmune, and inflammatory diseases using a combination of an inosine monophosphate dehydrogenase (IMPDH) inhibitor and a HMG CoA reductase inhibitor.
    Type: Application
    Filed: December 9, 2010
    Publication date: November 3, 2011
    Applicant: Aspreva International Ltd.
    Inventors: Michael HAYDEN, Noel Hall
  • Publication number: 20100010082
    Abstract: The present disclosure relates to ophthalmic solutions and methods of using the solutions to treat ocular disorders
    Type: Application
    Filed: July 9, 2009
    Publication date: January 14, 2010
    Applicant: Aspreva International Ltd.
    Inventors: Eddie CHONG, Clive BURGE, Lee MIZZEN